Video summary

Tesamorelin + Retatrutide: Should You Stack Them for Fat Loss

Main summary

Key takeaways

Wellness and Self-Improvement

Key Wellness Strategies / Self-Care & Productivity Tips Discussed

Ask the Right Question (Outcome-Focused)

Instead of asking, “Which stacking is best for faster fat loss?”, focus on whether the combination can help reverse metabolic disease, such as:

  • Visceral fat
  • Insulin resistance
  • Fatty liver

Prioritize Visceral-Fat Reduction + Preserve Muscle (Core Goal)

The speaker emphasizes that “dropping scale weight” often fails when:

  • You lose muscle, and
  • Visceral fat remains

Core goal: reduce visceral fat (fat around organs) while maintaining muscle mass to improve metabolic health.

Use the “Foundation First” Approach (Non-Negotiables)

Key non-negotiables include:

  • Protein targets are mandatory to prevent muscle loss
  • Resistance training is mandatory to preserve muscle
  • Fasting windows still matter Peptides are meant to amplify behavior, not replace it.

Avoid the “Kitchen Sink” Mistake (Sequencing for Clarity + Safety)

  • Do not start both compounds at the same time.
  • Reason: if side effects or changes occur, you won’t know which compound caused what.

Clinic Sequencing Strategy (Stack Logic)

Step 1: Start Retatrutide First

Start with Retatrutide (described as similar to a tirzepatide-style signaling approach involving GLP-1/GIP plus unique glucagon signaling).

Purpose:

  • Establish a metabolic baseline
  • Improve appetite control
  • Observe side effects over 2–4+ weeks

Step 2: Add Tesamorelin After Response Is Stable

Add Tesamorelin afterward once the response to Retatrutide is stable.

Purpose:

  • Target visceral fat specifically

Tesamorelin Timing + Cycling Strategy (Off-Label Notes)

Timing

  • Take away from meals—especially away from carbohydrates—because food can dampen growth hormone release.

Suggested approach (as described)

  • Empty stomach / evening dosing (before bed)
  • Example pattern: ~500 mcg–1,000 mcg, 5 days on / 2 days off

Important note on dosing

  • The speaker contrasts clinic use with FDA-labeled HIV lipodystrophy dosing (noted as ~1–2 mg/day), suggesting clinics may use different dosing/cycling.

Always use proper medical supervision (because this is off-label).

Why Each Drug Is Used (Two Different “Root Causes”)

  • Tesamorelin → growth hormone axis

    • Targets visceral fat more directly by shrinking depot fat around organs.

  • Retatrutide → glucagon receptor + GLP-1/GIP

    • Aims to improve insulin resistance and metabolic flexibility by promoting energy mobilization—described as a fasting-like shift (less storage, more release).

Who the Stack Is “For”

People who have:

  • Significant visceral fat
  • Documented insulin resistance or fatty liver
  • Metabolic health/optimization goals, including “longevity” goals

Also implied: if foundation habits aren’t in place, the stack may not deliver the intended benefits.

Who May Not Need as Much Retatrutide

For “health optimizers” not in crisis, the speaker suggests lower Retatrutide may be sufficient (around 1–2 mg mentioned).

Presenters / Sources

  • Dr. Jones, DC — speaker; GLP-1s and peptides coach/medical educator
  • FDA — referenced for Tesamorelin approval indication: HIV-associated lipodystrophy

Original video